- Multitargeting nature of muscarinic orthosteric agonists and antagonists2022 | First Faculty of Medicine
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publication without faculty affiliation
- Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer's disease2018 | Publication without faculty affiliation
- Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases2017 | Publication without faculty affiliation
- Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease2016 | Publication without faculty affiliation
- Multitarget Drug Design Strategy: Quinone-Tacrine Hybrids Designed To Block Amyloid-beta Aggregation and To Exert Anticholinesterase and Antioxidant Effects2014 | Publication without faculty affiliation
- Novel 8-Hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer's disease2016 | Publication without faculty affiliation
- Crizotinib - multitargeted inhibitor in targeted NSCLC therapyPublication without faculty affiliation
- Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease2017 | Publication without faculty affiliation
- Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile2022 | Publication without faculty affiliation
- Crizotinib - a multitargeted inhibitor as a molecularly targeted treatment in non small cell lung cancer2013 | Publication without faculty affiliation
- N-Alkyl-2-[4-(trifluoromethyl)benzoyl]hydrazine-1-carboxamides and Their Analogues: Synthesis and Multitarget Biological Activity2020 | Faculty of Pharmacy in Hradec Králové
- Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment2021 | Publication without faculty affiliation
- Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease2021 | Publication without faculty affiliation
- Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimer's drugs dealing with cholinergic, amyloid and mitochondrial systems2021 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy2019 | Publication without faculty affiliation
- Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease2017 | Publication without faculty affiliation
- Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics2022 | Publication without faculty affiliation
- Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study2021 | First Faculty of Medicine
- Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease2016 | Publication without faculty affiliation
- Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis2018 | Faculty of Pharmacy in Hradec Králové
- Discovery of Dual A beta/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease2022 | Publication without faculty affiliation
- Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease2017 | Publication without faculty affiliation
- Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study2021 | Faculty of Pharmacy in Hradec Králové
- Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease2016 | Publication without faculty affiliation
- Regorafenib - the position of this drug in a current daily oncologic practice2019 | Publication without faculty affiliation
- Ladostigil - another pursuit of a dual action cognitive enhancer2013 | Publication without faculty affiliation
- A new look at 9-substituted acridines with various biological activities2021 | Publication without faculty affiliation
- Effect of Tapentadol on Experimental Model of Orofacial Pain - a Pilot Study2020 | First Faculty of Medicine, Third Faculty of Medicine
- (+/-)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3 beta Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease2021 | Publication without faculty affiliation
